Basilea Pharmaceutica AG (BPMUF) Stock Overview
Explore Basilea Pharmaceutica AG’s financial performance, market position, analyst ratings, and future outlook.
Basilea Pharmaceutica AG (BPMUF)
Key Financials
Key Financials
Market Cap
746M
P/E Ratio
14.57
EPS (TTM)
$7.12
ROE
0.35%
BPMUF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Basilea Pharmaceutica AG (BPMUF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $70.77.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.57 and a market capitalization of 746M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.